Strategic Financial Services Inc. Buys 5,079 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Strategic Financial Services Inc. increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 248,521 shares of the exchange traded fund’s stock after acquiring an additional 5,079 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 1.3% of Strategic Financial Services Inc.’s portfolio, making the stock its 17th largest position. Strategic Financial Services Inc. owned approximately 0.33% of SPDR S&P Biotech ETF worth $22,382,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Kohmann Bosshard Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the period. Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $43,000. Finally, Addison Advisors LLC grew its position in SPDR S&P Biotech ETF by 27.4% in the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after purchasing an additional 115 shares during the period.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA XBI opened at $87.46 on Thursday. The company has a fifty day simple moving average of $89.75 and a 200 day simple moving average of $94.53. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The company has a market cap of $5.67 billion, a P/E ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.